According to Zhitong Finance App News, Tianchen Bio-B (01779) announced that according to the “Notice Concerning the Adjustment of the Shanghai-Hong Kong Stock Exchange” issued by the Shanghai Stock Exchange on September 4, 2026 and the “Notice Concerning the Adjustment of the List of Hong Kong Stock Exchange under the Shenzhen-Hong Kong Stock Connect Securities List” issued by the Shenzhen Stock Exchange on September 7, 2026, the company has been included in the list of eligible securities under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Program. Once the company's shares are included in the list of eligible securities, eligible investors in mainland China will be able to directly trade shares through the Shanghai Stock Exchange and Shenzhen Stock Exchange.

The board of directors believes that the shares were included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Exchange trading mechanisms, which shows that the market is highly appreciative of the company's investment value and growth prospects. The company expects that the inclusion of shares in the list of eligible securities will help further expand the shareholder base and attract more long-term institutional investors, increase the trading liquidity of shares, and lay a solid foundation for the company's long-term development, thereby enhancing the company's investment value and reputation in the capital market.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.